cannabidiol
11/19/2017
/
By Ethan Huff
Protecting its interests: FDA attacks CBD supplements to protect Big Pharma’s opioid profits
Big Pharma is working overtime to restrict consumer access to cannabidiol, or CBD, a non-psychoactive component of cannabis sativa (marijuana) that’s been shown to help relieve pain, muscle spasms, and other ailments. Using the U.S. Food and Drug Administration (FDA) as authoritative cover, the industry is quietly leading the charge to ban CBD from being […]
« Return Home
1 of 1
Popular Articles
COPYRIGHT © 2017 OPIOIDS NEWS
Privacy Policy